Movement Alert｜Haleon Falls 11.8% in Pre-Market Trading, trading at 8.79

Market Focus10-29

On October 29, Haleon fell 11.8% in Pre-Market Trading, trading at $8.79 per share, with Turnover of $658,500.

Within the Pharmacy sector where Haleon belongs, peer moves were mixed rather than broadly weak: Eli Lilly up 1.68%, Johnson & Johnson down 0.33%, Merck up 1.61%, Pfizer up 1.09%, and Bristol-Myers Squibb up 1.27%.

Recent company disclosures in the available public information include stronger first-half results reported on July 30, with adjusted EPS rising year over year and revenue modestly ahead of expectations, as well as August debt tender activity aimed at optimizing the debt portfolio. However, the available information does not identify a specific same-day catalyst for the current pre-market fall.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment